Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Nuvalent Reports Preliminary Phase 1 Clinical Data From ALKOVE-1 Trial; Says Safety Profile Is Consistent With An ALK-Selective, TRK Sparing Design

Author: Bill Haddad | October 13, 2023 06:31am

Posted In: NUVL